Acumen Pharmaceuticals (ABOS) Shares Outstanding (2020 - 2026)
Acumen Pharmaceuticals (ABOS) Shares Outstanding (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Acumen Pharmaceuticals | 137.50 Mn | 137.50 Mn | - | 63.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.22 Mn |
| Dec 31, 2025 | 60.56 Mn |
| Sep 30, 2025 | 60.57 Mn |
| Jun 30, 2025 | 60.57 Mn |
| Mar 31, 2025 | 60.53 Mn |
| Dec 31, 2024 | 60.01 Mn |
| Sep 30, 2024 | 60.08 Mn |
| Jun 30, 2024 | 60.08 Mn |
| Mar 31, 2024 | 59.81 Mn |
| Dec 31, 2023 | 48.61 Mn |
| Sep 30, 2023 | 54.23 Mn |
| Jun 30, 2023 | 41.03 Mn |
| Mar 31, 2023 | 41.03 Mn |
| Dec 31, 2022 | 40.60 Mn |
| Sep 30, 2022 | 40.50 Mn |
| Jun 30, 2022 | 40.50 Mn |
| Mar 31, 2022 | 40.47 Mn |
| Dec 31, 2021 | 20.06 Mn |
| Sep 30, 2021 | 38.27 Mn |
| Jun 30, 2021 | 432,325.00 |